Dr. Neri and Dr. Bahlis will be presenting an informative update on the most recent advances in Myeloma treatment from the American Society of Hematology (ASH) Conference. Read more…
Read More
The Government of Alberta and Alberta Health Services (AHS) have announced that CAR-T Gene therapy will now become approved within the province. See announcement…
Read More
SAMPS would like our membership to be aware of the recent changes by AHS to the Vaccination Schedule for Immunocompromised Patients. More details…
Read More
The American Society of Hematology has released a study, Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose. This study supports the results of a recent UK study, encouraging manufacturer’s recommendations for vaccination timing be followed in cancer patients. Read Report…
Read More
SAMPS is closely watching conversations around recommendations that the interval between the first and second COVID-19 vaccine dose be extended up to 4 months, and exceptions to this rule. Read more…
Read More